PeptideDB

SARS-CoV-2-IN-41

CAS: 2920904-06-7 F: C22H30F3N5O4S2 W: 549.63

SARS-CoV-2-IN-41 (compound 2) is a potent SARS-CoV-2 3CLpro inhibitor with an IC50 value of 0.022 µM. SARS-CoV-2-IN-41
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity SARS-CoV-2-IN-41 (compound 2) is a potent SARS-CoV-2 3CLpro inhibitor with an IC50 value of 0.022 µM. SARS-CoV-2-IN-41 shows antiviral effect[1].
Target IC50: 0.022 µM (SARS-CoV-2 3CLpro)
In Vivo SARS-CoV-2-IN-41 (50、200 mg/kg;腹腔注射) 对 SARS-CoV-2 感染小鼠的抗病毒作用[1]。 Animal Model:
Name SARS-CoV-2-IN-41
CAS 2920904-06-7
Formula C22H30F3N5O4S2
Molar Mass 549.63
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. XiangRui et al. Cyano compound, and preparation method therefor and use thereof. WO2023051657A1.